• 2026 – 2028: Who could have succeeded? From observed to plausible inference across University Admission Selection Rules. FONDECYT 11260407, Chilean Government. Principal Investigator.
  • 2026 – 2027: Bridging methodological gaps in assessing the social impact of rehabilitation: a multidisciplinary approach to spinal cord injury [RPG25102]. Research partnership grant 2025, Switzerland. Researcher
  • 2022 – 2024: Development of Modelling Tools for a Predictive Validity Agenda for University Admissions. FONDECYT 3220422, Chilean Government. Principal Investigator.
  • 2022 – 2024: Admisión universitaria más allá de la selección. FONDEF IDeA I+D ID22I10228, Chilean Government. Researcher.
  • 2022 – 2024: Millenium Nucleus on Intergenerational Mobility: From Modelling to Policy. Iniciativa Milenio NCS2021072, Chilean Government. Postdoctoral researcher.
  • 2021 – 2022: Estudio clínico multicéntrico de fase 3, doble ciego, aleatorizado, controlado con placebo, para evaluar la eficacia, inmunogenicidad y seguridad de una vacuna contra COVID19 (células Vero), inactivada (CoronaVac®), en niños y adolescentes de 6 meses a 17 años (PedCoronaVac03CL). Sinovac Life Sciences Co., Ltd. Data Manager and Statistician.